PathAI Funding History

PathAI develops AI algorithms and digital pathology platforms used in diagnostics and biopharma research.

Company Overview

PathAI

Healthcare

Founded 2016 · Boston, Massachusetts, US

Official Website

PathAI Funding Timeline

May 18, 2021
Series C
US$165 million
Led by D1 Capital, Kaiser Permanente Ventures.
Source · pathai.com ↗
Nov 11, 2019
Series B Extension
US$75 million
Led by Tiger Global.
Source · pathai.com ↗
Apr 17, 2019
Series B
US$60 million
Source · pathai.com ↗
Nov 15, 2017
Series A
US$11 million
Led by General Catalyst.
Source · fiercebiotech.com ↗

PathAI Founding Team

Andrew Beck
Co-founder and CEO of PathAI; MD-PhD pathologist formerly at Beth Israel Deaconess and Harvard.
Status: activeReviewed: 2026-11-04
Aditya Khosla
Co-founder of PathAI; MIT computer-vision researcher, later CTO of Iterative Scopes.
Status: activeReviewed: 2026-11-04
David Klimstra
Co-founder of PathAI.
Status: activeReviewed: 2026-11-04

PathAI Products

AISight
Digital pathology platform for managing and analyzing tissue images.
Official Website ↗
Details and Sources
Status: activeReviewed: 2026-11-05
Sources:pathai.com